CRISPR gene editing in human embryos wreaks chromosomal mayhem

Three studies showing large DNA deletions and reshuffling heighten safety concerns about heritable genome editing.

A suite of experiments that use the gene-editing tool CRISPR–Cas9 to modify human embryos have revealed how the process can make large, unwanted changes to the genome at or near the target site.

The studies were published this month on the preprint server bioRxiv, and have not yet been peer-reviewed1,2,3. But taken together, they give scientists a good look at what some say is an underappreciated risk of CRISPR–Cas9 editing. Previous experiments have revealed that the tool can make ‘off target’ gene mutations far from the target site, but the nearby changes identified in the latest studies can be missed by standard assessment methods.

Wie Traumata unsere Gehirnzellen prägen

Tierversuche bleiben wichtig

Mehr als Genchirurgie: Schwerpunktprogramm zu CRISPR-Cas verlängert

Anti-CRISPR proteins could help put the brakes on gene editing

Cancer du poumon: espoir d'une immunothérapie plus efficace

CRISPR gene therapy shows promise against blood diseases